Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
about
Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparumArtemisinin-resistant malaria: research challenges, opportunities, and public health implicationsA molecular marker of artemisinin-resistant Plasmodium falciparum malariaDrug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drugDrug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and GiardiaComputational and Practical Aspects of Drug RepositioningDrug resistance genomics of the antimalarial drug artemisininDrug repurposing and human parasitic protozoan diseasesApplication of genomics to field investigations of malaria by the international centers of excellence for malaria researchMalarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised targetA HECT ubiquitin-protein ligase as a novel candidate gene for altered quinine and quinidine responses in Plasmodium falciparumPfCRT and its role in antimalarial drug resistanceProtein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparumA genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in KenyaHigh sensitivity of Giardia duodenalis to tetrahydrolipstatin (orlistat) in vitroNovel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of AssaysMolecular Mechanisms for Drug Hypersensitivity Induced by the Malaria Parasite's Chloroquine Resistance TransporterPfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockersMultiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter at distinct but interdependent sitesMutations in the Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL) Confer Multidrug ResistanceDrug resistance in eukaryotic microorganisms.High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinationsMalaria pigment crystals as magnetic micro-rotors: key for high-sensitivity diagnosis.Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in KenyaChlorpheniramine Analogues Reverse Chloroquine Resistance in Plasmodium falciparum by Inhibiting PfCRT.A Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug PiperaquineDiverse mutational pathways converge on saturable chloroquine transport via the malaria parasite's chloroquine resistance transporterA cross-sectional survey of Plasmodium falciparum pfcrt mutant haplotypes in the Democratic Republic of Congo.Genome-wide polymorphisms and development of a microarray platform to detect genetic variations in Plasmodium yoelii.Exploring anti-malarial potential of FDA approved drugs: an in silico approach.Molecular surveillance of pvdhfr, pvdhps, and pvmdr-1 mutations in Plasmodium vivax isolates from Yunnan and Anhui provinces of ChinaQuantitative genome re-sequencing defines multiple mutations conferring chloroquine resistance in rodent malariaA class of tricyclic compounds blocking malaria parasite oocyst development and transmission.1H-NMR metabolite profiles of different strains of Plasmodium falciparum.Malaria biology and disease pathogenesis: insights for new treatments.A whole cell pathway screen reveals seven novel chemosensitizers to combat chloroquine resistant malaria.Integrating phenotypic small-molecule profiling and human genetics: the next phase in drug discovery.Model system to define pharmacokinetic requirements for antimalarial drug efficacy.Chemical genomics for studying parasite gene function and interaction.Predicting functional and regulatory divergence of a drug resistance transporter gene in the human malaria parasite
P2860
Q21032477-C2E3110E-8C3B-4CA1-81BA-267EE6CF0CCEQ21032532-13F224A0-D555-4308-A991-BADF1580D878Q22061872-BA1490F4-81AC-4B70-8FEB-33EA9EC2AB1BQ24613311-2EE0E144-7F21-4E73-9534-6FC5F138677EQ26774724-235790E3-FE1F-4F82-B9A0-FE9B08925A50Q26799146-E6D80A92-4006-4E22-8559-9FF69E36DB29Q26862789-6ACF2C28-97DE-4ED0-BB18-56BC570B0A3FQ26999453-4083FB92-C45B-4A6B-BE68-31CEDBD47616Q27010267-DCA426B1-DE68-4875-AC6B-BF1842A6D390Q27674154-A4A6226C-208E-4D35-87F6-9BC5CC3CA4FFQ27861949-CF519203-D806-4537-8E10-909E417F77B5Q27861957-C8EE5E8C-DC8B-4454-BC98-692E50C15A1EQ27973776-F85163BF-413D-42D1-A1A4-FA456AF138A1Q28031418-2B80AF07-DD63-4032-8F50-876692DFFAECQ28535443-D0622C38-2CFC-4A17-A697-A7D3E3EB96B4Q28546583-8582E9BB-0BA2-4569-8876-FBF492CFFE89Q28552775-E2E7E2C1-246B-4791-ABF6-6EA2D00F9428Q28833540-5B934AC1-4A28-47A6-B7B8-C9BEB8C49C5AQ30041687-4B745D35-79C0-4801-86F8-29DEA644C930Q30047024-0A7B04F0-28F6-49EB-BC39-4E9FD2A8F329Q30248243-36A3CE40-5142-4F53-A5B2-F5B9E29E2651Q30402235-10FA31D1-1791-48E1-B79C-EA7E89C01656Q30537450-CCDD287B-731F-462E-8198-F5FD110C2621Q31076495-3E98D781-B1AA-459A-A749-BA211D961FFCQ33636449-2E528342-A4BF-4EB8-B989-654916F41E43Q33654512-DC946212-BC96-4E60-B1CA-015A38782158Q33674606-0A788109-5B1B-4402-8E8F-61FA93F6C56DQ33719592-0720D6F7-08F4-4E92-A827-F47945B74045Q33737114-16A8A10D-C8B6-456B-8B30-B111CA077941Q33916846-28950147-EFB9-441B-A20D-750D0F130716Q34168392-F6F7B70E-A8F3-4254-94B4-6B6EDA111B40Q34204687-1951EC8A-AF54-4698-BF68-CE34C14A8521Q34467923-FE7284B7-3B02-471A-94AA-A2AEC16F6B33Q34554760-AB962137-256A-4271-946F-0BAD3E356581Q34579700-80C7282E-7B8A-4936-9DCE-D1752D743503Q34686526-946B6262-608C-47E2-9DEC-0E8101E385D2Q34797680-2B3D3ADB-3B5D-41CF-8F00-D571521E31B3Q35007051-83022203-D7D0-4F56-8A7F-C7D4FB2139C9Q35038521-2AF628FC-4335-48D2-A455-AAEA63BB341EQ35156257-9014879F-906B-44A8-BC88-C2014272D6AA
P2860
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Chemical genomic profiling for ...... atures, and molecular targets.
@ast
Chemical genomic profiling for ...... atures, and molecular targets.
@en
type
label
Chemical genomic profiling for ...... atures, and molecular targets.
@ast
Chemical genomic profiling for ...... atures, and molecular targets.
@en
prefLabel
Chemical genomic profiling for ...... atures, and molecular targets.
@ast
Chemical genomic profiling for ...... atures, and molecular targets.
@en
P2093
P2860
P356
P1433
P1476
Chemical genomic profiling for ...... atures, and molecular targets.
@en
P2093
Christopher P Austin
James Inglese
Ken Chih-Chien Cheng
Rajarshi Guha
Ronald L Johnson
Ruili Huang
Sittiporn Pattaradilokrat
Thomas E Wellems
P2860
P304
P356
10.1126/SCIENCE.1205216
P407
P577
2011-08-01T00:00:00Z